See more : NIO Inc. (NIO) Income Statement Analysis – Financial Results
Complete financial analysis of HAEMATO AG (HAEK.DE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HAEMATO AG, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Beijing Tianyishangjia New Material Corp., Ltd. (688033.SS) Income Statement Analysis – Financial Results
- Amadeus FiRe AG (AAD.DE) Income Statement Analysis – Financial Results
- Candy Club Holdings Limited (CLB.AX) Income Statement Analysis – Financial Results
- Yokohama Gyorui Co., Ltd. (7443.T) Income Statement Analysis – Financial Results
- Grupo Aeroportuario del Sureste, S. A. B. de C. V. (ASRMF) Income Statement Analysis – Financial Results
HAEMATO AG (HAEK.DE)
About HAEMATO AG
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic medicine, as well as cosmetic products. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, and medical laboratories. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 248.14M | 285.04M | 238.33M | 197.83M | 274.12M | 289.44M | 275.61M | 229.73M | 202.67M | 173.57M | 25.04M | 10.85M | 23.71M | 4.11M | 13.79M | 43.07M |
| Cost of Revenue | 232.84M | 263.29M | 229.18M | 192.46M | 253.00M | 269.51M | 256.14M | 214.41M | 186.38M | 165.39M | 17.92M | 8.08M | 22.93M | 4.18M | 4.91M | 37.65M |
| Gross Profit | 15.30M | 21.75M | 9.15M | 5.38M | 21.12M | 19.93M | 19.47M | 15.32M | 16.30M | 8.18M | 7.12M | 2.78M | 778.41K | -67.65K | 8.89M | 5.43M |
| Gross Profit Ratio | 6.17% | 7.63% | 3.84% | 2.72% | 7.71% | 6.88% | 7.06% | 6.67% | 8.04% | 4.71% | 28.43% | 25.60% | 3.28% | -1.65% | 64.43% | 12.60% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.94M | 11.05M | 8.02M | 6.85M | 6.32M | 6.21M | 5.06M | 5.41M | 4.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 932.51K | 457.74K | 480.79K | 1.46M | 1.19M | 631.04K | -15.24K | -3.07K | 0.00 | 0.00 | 0.00 | 1.24M | 817.66K | -791.39K | -180.57K | -294.00K |
| Operating Expenses | 7.01M | 10.59M | 7.53M | 5.40M | 12.62M | 10.54M | 6.04M | 7.67M | 8.07M | 1.74M | -2.07M | 1.59M | -5.05M | 3.22M | 4.99M | 2.45M |
| Cost & Expenses | 239.85M | 273.88M | 236.71M | 197.86M | 265.62M | 280.05M | 262.19M | 222.07M | 194.44M | 167.12M | 15.86M | 9.67M | 17.88M | 7.40M | 9.89M | 40.09M |
| Interest Income | 631.75K | 358.35K | 4.14K | 8.24K | 739.26K | 1.33M | 1.18M | 1.63M | 1.37M | 927.00K | 257.27K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 358.51K | 422.77K | 803.44K | 771.89K | 1.08M | 1.96M | 1.86M | 1.64M | 1.55M | 1.37M | 683.43K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.37M | 1.43M | 1.69M | 1.92M | 1.46M | 1.85M | 1.81M | 1.80M | 2.06M | 1.81M | 850.13K | 2.91M | 1.52M | 836.55K | 194.22K | 311.00K |
| EBITDA | 12.21M | 12.64M | -2.07M | 1.50M | 8.01M | 11.90M | 15.92M | 10.03M | 10.47M | 12.19M | 10.30M | 5.40M | 8.25M | -1.97M | 4.09M | 4.18M |
| EBITDA Ratio | 3.89% | 4.43% | 1.39% | 0.96% | 2.92% | 1.87% | 2.02% | 2.19% | 2.95% | 5.24% | 41.12% | 37.75% | 31.00% | -47.95% | 29.68% | 7.64% |
| Operating Income | 8.30M | 11.16M | 1.62M | -22.56K | 6.56M | 3.54M | 3.77M | 3.23M | 3.93M | 7.28M | 9.19M | 1.19M | 5.82M | -3.29M | 3.90M | 2.98M |
| Operating Income Ratio | 3.34% | 3.92% | 0.68% | -0.01% | 2.39% | 1.22% | 1.37% | 1.40% | 1.94% | 4.19% | 36.69% | 10.93% | 24.57% | -80.12% | 28.27% | 6.91% |
| Total Other Income/Expenses | 2.19M | -1.80M | -6.19M | -1.17M | 1.20M | 3.89M | 9.02M | 4.38M | 2.94M | 1.72M | -489.11K | 620.00K | -184.20K | -2.09M | -518.55K | -613.00K |
| Income Before Tax | 10.48M | 9.36M | -4.56M | -1.19M | 7.76M | 8.06M | 12.24M | 6.03M | 6.87M | 8.99M | 8.70M | 1.81M | 5.64M | -5.38M | 3.38M | 2.36M |
| Income Before Tax Ratio | 4.23% | 3.28% | -1.91% | -0.60% | 2.83% | 2.78% | 4.44% | 2.62% | 3.39% | 5.18% | 34.73% | 16.64% | 23.79% | -130.94% | 24.51% | 5.49% |
| Income Tax Expense | 2.29M | 2.82M | 268.88K | -19.31K | 1.48M | 1.10M | 1.21M | 486.00K | 112.00K | 611.00K | 1.28M | 144.70K | -62.87K | 301.79K | -628.95K | -889.00K |
| Net Income | 8.19M | 6.53M | -4.83M | -1.17M | 6.28M | 6.98M | 11.04M | 5.54M | 6.98M | 7.94M | 6.84M | 1.48M | 5.70M | -5.68M | 3.98M | 2.84M |
| Net Income Ratio | 3.30% | 2.29% | -2.03% | -0.59% | 2.29% | 2.41% | 4.00% | 2.41% | 3.44% | 4.57% | 27.30% | 13.65% | 24.06% | -138.29% | 28.87% | 6.60% |
| EPS | 1.57 | 1.25 | -1.02 | -0.51 | 2.80 | 3.24 | 5.31 | 2.67 | 3.36 | 4.05 | 3.40 | 1.10 | 4.20 | -6.20 | 4.30 | 3.10 |
| EPS Diluted | 1.57 | 1.25 | -1.02 | -0.51 | 2.80 | 3.24 | 5.31 | 2.67 | 3.36 | 4.05 | 3.40 | 1.10 | 4.20 | -6.20 | 4.30 | 3.10 |
| Weighted Avg Shares Out | 5.21M | 5.21M | 4.73M | 2.28M | 2.24M | 2.15M | 2.08M | 2.08M | 2.08M | 1.96M | 2.03M | 1.37M | 1.37M | 916.05K | 923.29K | 918.47K |
| Weighted Avg Shares Out (Dil) | 5.21M | 5.21M | 4.73M | 2.28M | 2.24M | 2.15M | 2.08M | 2.08M | 2.08M | 1.96M | 2.03M | 1.37M | 1.37M | 916.05K | 923.29K | 918.47K |
Source: https://incomestatements.info
Category: Stock Reports